Cargando…
Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia
Abnormal coagulation properties indicative of a dysfibrinogenemia were found in the plasma of an asymptomatic 65-year-old male. An immunoglobulin k light chain was found to interfere with Fg functional assay and coagulation tests (activated partial thromboplastin time, prothrombin time, and thrombin...
Autores principales: | Martini, Francesca, Cecconi, Nadia, Paolicchi, Aldo, Galimberti, Sara, Cervetti, Giulia, Buda, Gabriele, Petrini, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524915/ https://www.ncbi.nlm.nih.gov/pubmed/31249984 http://dx.doi.org/10.1055/s-0039-1683969 |
Ejemplares similares
-
Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding
por: Li, Yang, et al.
Publicado: (2023) -
Fibrinogen Yecheon: Congenital Dysfibrinogenemia with Gamma Methionine-310 to Threonine Substitution
por: Park, Eunkyung, et al.
Publicado: (2009) -
Fibrinogen Longmont: A Clinically Heterogeneous Dysfibrinogenemia with Discrepant Fibrinogen Results Influenced by Clot Detection Method and Reagent
por: Leung, Becky, et al.
Publicado: (2022) -
Pseudohomozygous dysfibrinogenemia
por: Peck, Rachel C., et al.
Publicado: (2021) -
Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia
por: Mazziotta, Francesco, et al.
Publicado: (2019)